12 employees
OCT is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research.
2017
$10M
from 1 investors over 1 rounds
Oxford Cannabinoid Technologies Holdings Plc raised $10M on June 29, 2018
Investors: Casa Verde Capital